Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
New BHF Chief Technology Officer Appointed
British Heart Foundation are delighted to have appointed Alex Duncan as their new Chief Technology Officer (CTO). Alex, who is […]
NRx Pharmaceuticals Appoints Ira Strassberg as Chief Financial Officer and Treasurer
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage pharmaceutical company, announced today that the company’s Board of Directors […]
enGene Appoints James C. Sullivan, PhD as Chief Scientific Officer
enGene Inc., a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal […]
Elevation Oncology Appoints David Dornan, Ph.D., as Chief Scientific Officer
Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical-stage biopharmaceutical company focused on the development of precision medicines […]
Orexo Appoints Fredrik Järrsten as New CFO
Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), announces today that the company has appointed Fredrik Järrsten as […]
Solvias Appoints Archie Cullen Chief Executive Officer
Solvias, one of the largest independent analytical testing, contract research, development and manufacturing companies, today […]
AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer
AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announce that Dr. […]
Kit Check Hires New Chief Financial Officer
Kit Check, the leader in Medication Intelligence™ solutions that bring cost savings, efficiency, and patient […]
Bayer Announces Changes in Executive Leadership Team of Crop Science Division
Bayer today announced changes in the leadership team of its Crop Science division, with Kelly […]
Owkin Welcomes Leading Immuno-oncology Professor as Chief Medical Officer and Senior Pharma Exec as SVP Data Science
Owkin appointed Professor Vassili Soumelis as Chief Medical Officer and Eric Durand as SVP Data […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more